Oculis Holding AG (OCS) Short-term Investments (2023 - 2026)
Oculis Holding AG's (OCS) quarterly Short-term Investments came in at $201.1 million in Q1 2026, up 48.13% year-on-year from $135.8 million in Q1 2025, and up 22.05% quarter-over-quarter from $164.8 million in Q4 2025.
Oculis Holding AG (OCS) Short-term Investments (2023 - 2026) Analysis & Trends
Oculis Holding AG's Short-term Investments history runs 4 years deep, the most recent figure standing at $201.1 million for Q1 2026.
- On a quarterly basis, Short-term Investments rose 48.13% year-over-year to $201.1 million in Q1 2026; TTM through Mar 2026 was $201.1 million, a 48.13% increase from a year earlier, with the FY2025 full-year figure at $158.8 million, up 96.92% from the prior year.
- Short-term Investments grew to $201.1 million in Q1 2026 per OCS's latest filing, from $164.8 million in the prior quarter.
- Across five years, Short-term Investments topped out at $201.1 million in Q1 2026 and bottomed at -$85.9 million in Q3 2023.
- The 4-year median for Short-term Investments is $81.5 million (2024), against an average of $68.4 million.
- Across the five-year window, Short-term Investments surged 232.65% in 2024 and surged 41.63% in 2025, its largest moves.
- Year by year, Short-term Investments stood at -$61.1 million in 2023, then jumped by 232.65% to $81.0 million in 2024, then jumped by 103.41% to $164.8 million in 2025, then rose by 22.05% to $201.1 million in 2026.
- Per Business Quant, the three latest OCS Short-term Investments figures stand at $201.1 million (Q1 2026), $164.8 million (Q4 2025), and $123.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201.09 Mn |
| Dec 31, 2025 | 164.76 Mn |
| Sep 30, 2025 | 123.44 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Mar 31, 2025 | 135.76 Mn |
| Dec 31, 2024 | 81.00 Mn |
| Sep 30, 2024 | 80.61 Mn |
| Jun 30, 2024 | 81.91 Mn |
| Mar 31, 2024 | 63.67 Mn |
| Dec 31, 2023 | -61.06 Mn |
| Sep 30, 2023 | -85.90 Mn |
| Jun 30, 2023 | -80.16 Mn |